Related Experiment Video
Updated: Jun 24, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Nicorandil to Prevent Contrast-Associated Kidney Injury in High-Risk PCI
Minqi Liao1, Weiliang Zhou1, Wenbin Wang1
1Department of Cardiology, Dongguan People's Hospital (The Tenth Affiliated Hospital of Southern Medical University), China (M.L., W.Z., W.W., Y. Yang, Y. Yao, G.Z., Zhihao Wu, X.Z., B.W., G.L., Z.L., Zhanyang Wei, J.L., Y.W., A.L., S.G.).
Oral nicorandil significantly reduced contrast-associated acute kidney injury in patients undergoing percutaneous coronary intervention with renal dysfunction. A dose of 10 mg three times daily proved effective, offering a new prophylactic strategy.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Patients with renal dysfunction face high risks of contrast-associated acute kidney injury (CA-AKI) despite standard care.
- Standard peri-procedural hydration may be insufficient for preventing CA-AKI in this vulnerable population.
Purpose of the Study:
- To investigate the efficacy of peri-procedural oral nicorandil in preventing CA-AKI.
- To evaluate the dose-response relationship of nicorandil for renoprotection.
Main Methods:
- A prospective, multicenter, randomized controlled trial was conducted.
- Patients with renal dysfunction undergoing percutaneous coronary intervention were randomized into high-dose nicorandil (30 mg/d), conventional-dose nicorandil (15 mg/d), or saline control groups.
- The primary endpoint was the incidence of CA-AKI.
Main Results:
- A total of 585 patients were enrolled.
- CA-AKI incidence was significantly lower in both nicorandil groups compared to the control group (10.9% and 8.7% vs. 19.8%, P<0.001).
- Relative risk reduction for CA-AKI was 50% for conventional-dose and 61% for high-dose nicorandil.
Conclusions:
- Adjunctive oral nicorandil, especially at 10 mg three times daily, significantly reduces CA-AKI in patients with renal dysfunction undergoing PCI.
- Oral nicorandil offers a readily available, effective, and dose-dependent prophylactic strategy for renoprotection.
- Further research is needed to assess long-term clinical benefits.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System V: CT
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...